MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $324,000 | +1196.0% | 127,700 | +946.7% | 0.00% | – |
| Q1 2020 | $25,000 | +4.2% | 12,200 | +8.9% | 0.00% | – |
| Q4 2019 | $24,000 | +14.3% | 11,200 | -17.0% | 0.00% | – |
| Q3 2019 | $21,000 | -89.4% | 13,500 | -71.8% | 0.00% | – |
| Q2 2019 | $199,000 | -11.2% | 47,900 | -10.5% | 0.00% | -100.0% |
| Q1 2019 | $224,000 | +53.4% | 53,500 | +5.5% | 0.00% | – |
| Q4 2018 | $146,000 | – | 50,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
| Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
| Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
| Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
| ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
| Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
| Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
| Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
| Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |